DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Krop IE, Kim SB, González-Martín A, LoRusso PM, Ferrero JM, Smitt M. et al.
Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): A randomised, open-label, phase 3 trial.
Lancet Oncol 2014;
15: 689-99
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.